1. Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials. Issue 3 (26th October 2017) Authors: Jabbour, Serge; Seufert, Jochen; Scheen, Andre; Bailey, Clifford J.; Karup, Cathrina; Langkilde, Anna M. Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 3(2018) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis. (July 2013) Authors: Scheen, Andre Journal: Expert opinion on drug safety Issue: Volume 12:Number 4(2013:Jul.) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBPS 02-49 IMPACT OF CHANGES IN GLUCOSE-LOWERING THERAPY ON ANALYSES OF GLYCEMIC CONTROL AND WEIGHT IN EMPA-REG OUTCOME. (September 2016) Authors: Lee, Dae Wook; Schernthaner, Guntram; Scheen, Andre; Johansen, Odd Erik; Zinman, Bernard Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗